Transformando el futuro de la industria farmacéutica
Email: info@amarintech.com.ar
Far away, in 1979, the first transdermal patch to reach the market, produced under an industrial controlled process and backed by clinical studies, was launched in US under the brand name TransderScop®. [...]
The Latin American surveillance health authorities have made progress year after year with respect to the requirements of product registration in general, seeking the best balance between the safety of its inhabitants, the efficacy of the products and the economic reality of each country. [...]
Para una empresa farmacéutica que evalúa desarrollar un sistema transdermal basado en una molécula ya aprobada en otra forma farmacéutica, la elección de la vía regulatoria es una de las decisiones estratégicas más determinantes del proyecto. [...]